Table 4 Clinical outcomes versus chronic glycemic control in patients with both diabetes and acute myocardial infarction.
|  | >HbA1c ≤ 7% (n = 156) | 7% < HbA1c < 9% (n = 122) | HbA1c ≥ 9% (n = 53) | p value |
|---|---|---|---|---|
Mortality | 20(12.8%) | 18(14.8%) | 5(9.4%) | 0.63 |
Cardiac arrest at admission | 4(2.6%) | 1(0.8%) | 1(1.9%) | 0.55 |
Cardiogenic shock | 32(20.5%) | 13(10.7%) | 7(13.2%) | 0.07 |
MACEs | 35(22.4%) | 19(15.6%) | 7(13.2%) | 0.19 |
VF, AV block, resuscitation | 51(32.7%) | 30(24.6%) | 13(24.5%) | 0.26 |
Acute respiratory failure | 46(29.5%) | 27(22.1%) | 12(22.6%) | 0.33 |
Acute heart failure | 122(78.2%) | 81(66.4%) | 36(67.9%) | 0.07 |
UGIB | 17(10.9%) | 14(11.5%) | 2(3.8%) | 0.26 |
Acute kidney injury | 92(59.0%) | 69(56.6%) | 16(30.2%) | 0.001* |
PCI | 125(80.1%) | 103(84.4%) | 40(75.5%) | 0.36 |
GRACE score | 183 ± 38 | 176 ± 41 | 164 ± 43 | 0.01* |
Hospital stay (days) | 17.0 ± 21.3 | 14.2 ± 20.3 | 9.0 ± 10.6 | 0.04* |
Glycemic gap (mg/dL) | 69.1 ± 93.8 | 54.2 ± 79.7 | 66.3 ± 105.1 | 0.39 |
